Treatment of HNSCC cells with CDDP resulted in phosphorylation and stabilization of p53 along with increased levels of p21 and PARP cleavage in HN30 cells which express wild type TP53 (Figure 1A). This evidence concerns the gene TP53 and head and neck squamous cell carcinoma.